Insulin resistance is known to be a key player in the development of HS, hence further research into the effects of GLP-1 agonists is needed as they stimulate glucose dependent insulin secretion
Although the relationship between GLP-1RAs and thyroid cancer risk remains uncertain, caution is advised when prescribing GLP-1RAs in individuals with a history of thyroid cancer or in those with higher risk [24]
A phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, Semaglutide, compared with placebo and open-label Liraglutide in patients with type 2 diabetes
For individuals managing obesity or weight-related health conditions, clinical treatments that mimic metabolic hormones have fundamentally shifted therapeutic expectations
The Science of Liposomal Delivery Because bioavailability is our core focus at Cymbiotika, we prioritize liposomal delivery for nutrients like glutathione that are otherwise difficult to absorb